Creating new tools to detect Candida infections early
Development of protease activity-based detector substrates for diagnosing Candida infections
This study is working on a new way to quickly spot harmful proteins made by Candida fungi, which can cause serious infections in people with weakened immune systems, so that doctors can catch these infections early and help patients get better faster.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biosynesis, INC. NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10676162 on NIH RePORTER |
What this research studies
This research focuses on developing innovative substrates that can detect the activity of proteases produced by Candida fungi, which are known to cause serious infections, especially in immunocompromised patients. By utilizing a novel mass spectrometry-based technology, the study aims to identify and measure protease activities in biological samples, allowing for rapid detection of biofilm formation associated with these infections. Early detection is crucial as it can lead to timely treatment and improved patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are immunocompromised individuals who are at high risk for serious Candida infections.
Not a fit: Patients who do not have a risk of Candida infections or those with non-immunocompromised conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the early diagnosis of Candida infections, potentially saving lives and improving treatment outcomes.
How similar studies have performed: Other research has shown promise in using mass spectrometry for detecting protease activities, indicating that this approach may lead to successful outcomes.
Where this research is happening
San Francisco, United States
- Biosynesis, INC. — San Francisco, United States (Active)
Researchers
- Principal investigator: Lohse, Matthew B. — Biosynesis, INC.
- Study coordinator: Lohse, Matthew B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.